Page 98 - MEMOCiberes014-ENG

RESEARCH GROUPS
Group 21
Programme: COPD / Lung Cancer / Pulmonary Fibrosis
Lead Researcher: Álvarez Martínez, Carlos Group members
STAFF MEMBERS: Castro Acosta, Ady Angelica | Fernandez Gonzalez, Saul
ASSOCIATED MEMBERS: Díaz de Atauri Rodríguez de los Rios, María Josefa | Enguita Valls, Ana Belén | Gámez García, Antonio Pablo | García Lujan, Ricardo | Gómez Sánchez, Miguel Ángel | Rami Porta, Ramón | Villena Garrido, María Victoria
Main lines of research
• •
•
• • •
Line NEOPLASIAS TORÁCCICAS LUNG CANCER AND PLEURA: Identify a set of clinical-molecular va- riables that improve the prognostic and predictive capacity of TNM and clinical translation of these results .
Line CHRONIC OBSTRUCTIVE PULMONARY DISEASE: To study the clinical, biological, microbiological, radiological, functional determinants of progression and severity . Evaluate new endoscopic treatment in obstructive airway disease and the impact of different approaches to health care in the manage- ment of disease activity .
Line PULMONARY HYPERTENSION (HP): Establish a network of groups with complementary capabili- ties of research aimed at identifying new markers for assessing disease activity and new therapeutic targets for the treatment of pulmonary hypertension following a strategy of translational research, with the ultimate aim of contributing to alleviate and cure the disease .
Line INSTERSTICIALES DISEASES AND FIBROSIS: Create a record of well-characterized patients, and incorporate new treatments in their care, measuring the impact on quality of life, progression and prevention of exacerbations .
Line SAHS & NO INVASIVE VENTILATION (NIV): Develop new ways of simplified diagnosis, deepen treatment indications and establish new indications for NIV outside the critical care units . Investigate the causes of failure of NIV and asynchrony .
Line RESEARCH IN LUNG TRANSPLANTATION: Advance knowledge of the causes of rejection and infection and diagnosis, and expand the selection criteria organ donor and recipient .
98
CIBERES » Annual report 2014